• Sign Up

Malignancy-Related Hypercalcemia


[1] Ramos REO,Perez Mak M,Alves MFS,Piotto GHM,Takahashi TK,Gomes da Fonseca L,Silvino MCM,Hoff PM,de Castro G Jr, Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes. Journal of global oncology. 2017 Dec;     [PubMed PMID: 29244985]
[2] Çullas İlarslan NE,Şıklar Z,Berberoğlu M, Childhood Sustained Hypercalcemia: A Diagnostic Challenge. Journal of clinical research in pediatric endocrinology. 2017 Dec 15;     [PubMed PMID: 28443817]
[3] Tagiyev A,Demirbilek H,Tavil B,Buyukyilmaz G,Gumruk F,Cetin M, Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate. Journal of pediatric hematology/oncology. 2016 Apr;     [PubMed PMID: 26907650]
[4] Mirrakhimov AE, Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. North American journal of medical sciences. 2015 Nov;     [PubMed PMID: 26713296]
[5] McCurdy MT,Shanholtz CB, Oncologic emergencies. Critical care medicine. 2012 Jul;     [PubMed PMID: 22584756]
[6] Maletkovic J,Isorena JP,Palma Diaz MF,Korenman SG,Yeh MW, Multifactorial hypercalcemia and literature review on primary hyperparathyroidism associated with lymphoma. Case reports in endocrinology. 2014;     [PubMed PMID: 24716007]
[7] Riancho JA,Arjona R,Valle R,Sanz J,González-Macías J, The clinical spectrum of hypocalcaemia associated with bone metastases. Journal of internal medicine. 1989 Dec;     [PubMed PMID: 2489231]
[8] Schiller JH,Rasmussen P,Benson AB 3rd,Witte RS,Bockman RS,Harvey HA,Siris ES,Citrin DL,Greco FA,Stock JL, Maintenance etidronate in the prevention of malignancy-associated hypercalcemia. Archives of internal medicine. 1987 May;     [PubMed PMID: 3107487]
[9] Hasling C,Charles P,Mosekilde L, Etidronate disodium in the management of malignancy-related hypercalcemia. The American journal of medicine. 1987 Feb 23;     [PubMed PMID: 3103436]